Melt Pharmaceuticals, Inc. (MELT)

Melt Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jan 4, 2023.

Stock Price: Pending

IPO price not available yet

Melt Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Selling, General & Admin	-	2.54	1.99
Research & Development	-	3.53	2.54
Operating Expenses	-	6.07	4.53
Operating Income	-8.67	-6.07	-4.53
Interest Expense / Income	1.5	0.58	-0.01
Pretax Income	-10.24	-6.65	-4.52
Income Tax	-0	0.01	0.02
Net Income	-10.24	-6.65	-4.54
Free Cash Flow	-7.28	-4.23	-4.49
EBITDA	-8.7	-6.05	-4.53
Depreciation & Amortization	0.03	0.01	0
EBIT	-8.73	-6.07	-4.53

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).